| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| ATAD2 | ESR1 | ENSSSCP00000046009 | ENSSSCP00000030835 | ATPase family AAA domain containing 2. | Estrogen receptor; Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE- independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial a [...] | 0.927 |
| CGA | LHB-2 | ENSSSCP00000046920 | ENSSSCP00000039170 | Glycoprotein hormones alpha chain; Shared alpha chain of the active heterodimeric glycoprotein hormones thyrotropin/thyroid stimulating hormone/TSH, lutropin/luteinizing hormone/LH and follitropin/follicle stimulating hormone/FSH. These hormones bind specific receptors on target cells that in turn activate downstream signaling pathways. | Lutropin subunit beta; Promotes spermatogenesis and ovulation by stimulating the testes and ovaries to synthesize steroids. | 0.977 |
| CITED1 | CREBBP | ENSSSCP00000057865 | ENSSSCP00000008490 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1. | CREB-binding protein isoform a. | 0.716 |
| CITED1 | EP300 | ENSSSCP00000057865 | ENSSSCP00000020812 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1. | E1A binding protein p300. | 0.869 |
| CITED1 | ESR1 | ENSSSCP00000057865 | ENSSSCP00000030835 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1. | Estrogen receptor; Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE- independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial a [...] | 0.543 |
| CITED1 | TFAP2A | ENSSSCP00000057865 | ENSSSCP00000053009 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1. | Transcription factor AP-2 alpha. | 0.541 |
| CITED1 | TFAP2B | ENSSSCP00000057865 | ENSSSCP00000039103 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1. | Transcription factor AP-2 beta. | 0.734 |
| CITED1 | TFAP2C | ENSSSCP00000057865 | ENSSSCP00000007991 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1. | Transcription factor AP-2 gamma (Activating enhancer binding protein 2 gamma). | 0.634 |
| CITED1 | TFAP2D | ENSSSCP00000057865 | ENSSSCP00000001901 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1. | Transcription factor AP-2 delta. | 0.541 |
| CITED1 | TFAP2E | ENSSSCP00000057865 | ENSSSCP00000038275 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1. | Transcription factor AP-2 epsilon. | 0.541 |
| CITED2 | CREBBP | ENSSSCP00000004474 | ENSSSCP00000008490 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2. | CREB-binding protein isoform a. | 0.922 |
| CITED2 | EP300 | ENSSSCP00000004474 | ENSSSCP00000020812 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2. | E1A binding protein p300. | 0.957 |
| CITED2 | TFAP2A | ENSSSCP00000004474 | ENSSSCP00000053009 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2. | Transcription factor AP-2 alpha. | 0.723 |
| CITED2 | TFAP2B | ENSSSCP00000004474 | ENSSSCP00000039103 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2. | Transcription factor AP-2 beta. | 0.627 |
| CITED2 | TFAP2C | ENSSSCP00000004474 | ENSSSCP00000007991 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2. | Transcription factor AP-2 gamma (Activating enhancer binding protein 2 gamma). | 0.649 |
| CITED2 | TFAP2D | ENSSSCP00000004474 | ENSSSCP00000001901 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2. | Transcription factor AP-2 delta. | 0.567 |
| CITED2 | TFAP2E | ENSSSCP00000004474 | ENSSSCP00000038275 | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2. | Transcription factor AP-2 epsilon. | 0.627 |
| CREBBP | CITED1 | ENSSSCP00000008490 | ENSSSCP00000057865 | CREB-binding protein isoform a. | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1. | 0.716 |
| CREBBP | CITED2 | ENSSSCP00000008490 | ENSSSCP00000004474 | CREB-binding protein isoform a. | Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2. | 0.922 |
| CREBBP | EP300 | ENSSSCP00000008490 | ENSSSCP00000020812 | CREB-binding protein isoform a. | E1A binding protein p300. | 0.997 |